Review Post-acute sequelae of SARS-CoV-2 infection (Long COVID) in older adults, 2024, Russell et al

• Samantha J. Russell,
• Karen Parker,
• Andrea Lehoczki,
• David Lieberman,
• Indu S. Partha,
• Serena J. Scott,
• Linda R. Phillips,
• Mindy J. Fain &
• Janko Ž. Nikolich

Abstract

Long COVID, also known as PASC (post-acute sequelae of SARS-CoV-2), is a complex infection-associated chronic condition affecting tens of millions of people worldwide. Many aspects of this condition are incompletely understood. Among them is how this condition may manifest itself in older adults and how it might impact the older population. Here, we briefly review the current understanding of PASC in the adult population and examine what is known on its features with aging. Finally, we outline the major gaps and areas for research most germane to older adults.

Paywall: https://link.springer.com/article/10.1007/s11357-024-01227-8

 

These are the papers on ME/CFS in the references section:

Apostolou E, Rizwan M, Moustardas P, et al. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome. Front Immunol. 2022;13:949787.

Campen C, Rowe PC, Visser FC. Orthostatic symptoms and reductions in cerebral blood flow in Long-Haul COVID-19 patients: similarities with myalgic encephalomyelitis/chronic fatigue syndrome. Medicina (Kaunas). 2021;58(1).

Aly M, Saber HG. Long COVID and chronic fatigue syndrome: a survey of elderly female survivors in Egypt. Int J Clin Pract. 2021;75(12):e14886.